Avidity Biosciences Inc (RNA)
26.03
+0.63
(+2.48%)
USD |
NASDAQ |
May 08, 16:00
26.03
0.00 (0.00%)
After-Hours: 17:52
Avidity Biosciences Total Assets (Quarterly): 628.56M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 628.56M |
| September 30, 2023 | 573.16M |
| June 30, 2023 | 610.78M |
| March 31, 2023 | 613.98M |
| December 31, 2022 | 638.80M |
| September 30, 2022 | 430.54M |
| June 30, 2022 | 420.80M |
| March 31, 2022 | 421.14M |
| December 31, 2021 | 427.58M |
| Date | Value |
|---|---|
| September 30, 2021 | 425.92M |
| June 30, 2021 | 290.52M |
| March 31, 2021 | 314.75M |
| December 31, 2020 | 333.90M |
| September 30, 2020 | 346.13M |
| June 30, 2020 | 355.36M |
| March 31, 2020 | 92.68M |
| December 31, 2019 | 96.91M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
92.68M
Minimum
Mar 2020
638.80M
Maximum
Dec 2022
413.03M
Average
421.14M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | 471.07M |
| Codexis Inc | 149.56M |
| Akoya Biosciences Inc | 180.37M |
| DocGo Inc | 490.45M |
| Kineta Inc | 10.28M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 127.79M |
| Shareholders Equity (Quarterly) | 500.76M |
| Current Ratio | 7.577 |